- Home
- RDY vs PEN Comparison
RDY vs PEN Comparison
Compare RDY & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDY
- PEN
- Stock Information
- Founded
- RDY 1984
- PEN 2004
- Country
- RDY India
- PEN United States
- Employees
- RDY N/A
- PEN N/A
- Industry
- RDY Biotechnology: Pharmaceutical Preparations
- PEN Medical/Dental Instruments
- Sector
- RDY Health Care
- PEN Health Care
- Exchange
- RDY Nasdaq
- PEN Nasdaq
- Market Cap
- RDY 11.6B
- PEN 9.7B
- IPO Year
- RDY N/A
- PEN 2015
- Fundamental
- Price
- RDY $13.48
- PEN $263.35
- Analyst Decision
- RDY Strong Buy
- PEN Strong Buy
- Analyst Count
- RDY 2
- PEN 16
- Target Price
- RDY $16.95
- PEN $307.81
- AVG Volume (30 Days)
- RDY 1.2M
- PEN 419.3K
- Earning Date
- RDY 10-24-2025
- PEN 11-05-2025
- Dividend Yield
- RDY 0.53%
- PEN N/A
- EPS Growth
- RDY 9.95
- PEN 370.35
- EPS
- RDY 0.79
- PEN 4.14
- Revenue
- RDY $3,851,623,984.00
- PEN $1,333,798,000.00
- Revenue This Year
- RDY $6.29
- PEN $15.52
- Revenue Next Year
- RDY $2.61
- PEN $14.20
- P/E Ratio
- RDY $17.15
- PEN $63.94
- Revenue Growth
- RDY 14.10
- PEN 14.61
- 52 Week Low
- RDY $12.26
- PEN $221.26
- 52 Week High
- RDY $16.17
- PEN $310.00
- Technical
- Relative Strength Index (RSI)
- RDY 37.81
- PEN 60.38
- Support Level
- RDY $13.38
- PEN $225.52
- Resistance Level
- RDY $13.52
- PEN $260.00
- Average True Range (ATR)
- RDY 0.25
- PEN 8.78
- MACD
- RDY -0.10
- PEN 0.41
- Stochastic Oscillator
- RDY 18.81
- PEN 82.95
About RDY Dr. Reddy's Laboratories Ltd
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
About PEN Penumbra Inc.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.